Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
Overview
Authors
Affiliations
Autosomal dominant polycystic kidney disease (ADPKD) constitutes the most inherited kidney disease. Mutations in the and genes, encoding the polycystin 1 and polycystin 2 Ca ion channels, respectively, result in tubular epithelial cell-derived renal cysts. Recent clinical studies demonstrate oxidative stress to be present early in ADPKD. Mitochondria comprise the primary reactive oxygen species source and also their main effector target; however, the pathophysiological role of mitochondria in ADPKD remains uncharacterized. To clarify this function, we examined the mitochondria of cyst-lining cells in ADPKD model mice (Ksp-Cre ) and rats (Han:SPRD ), demonstrating obvious tubular cell morphological abnormalities. Notably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) expression were decreased in ADPKD model animal kidneys, with PGC-1α expression inversely correlated with oxidative stress levels. Consistent with these findings, human ADPKD cyst-derived cells with heterozygous and homozygous mutation exhibited morphological and functional abnormalities, including increased mitochondrial superoxide. Furthermore, PGC-1α expression was suppressed by decreased intracellular Ca levels via calcineurin, p38 mitogen-activated protein kinase (MAPK), and nitric oxide synthase deactivation. Moreover, the mitochondrion-specific antioxidant MitoQuinone (MitoQ) reduced intracellular superoxide and inhibited cyst epithelial cell proliferation through extracellular signal-related kinase/MAPK inactivation. Collectively, these results indicate that mitochondrial abnormalities facilitate cyst formation in ADPKD.
Sun Y, Zou Q, Yu H, Yi X, Dou X, Yang Y EMBO Mol Med. 2024; 17(1):169-192.
PMID: 39567834 PMC: 11730739. DOI: 10.1038/s44321-024-00167-2.
Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD.
Cassina L, Boletta A EMBO Mol Med. 2024; 17(1):6-8.
PMID: 39567833 PMC: 11730632. DOI: 10.1038/s44321-024-00173-4.
Dynamic Kidney Organoid Microphysiological Analysis Platform.
Hong S, Song M, Miyoshi T, Morizane R, Bonventre J, Lee L bioRxiv. 2024; .
PMID: 39554191 PMC: 11565751. DOI: 10.1101/2024.10.27.620552.
Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases.
Dugbartey G, Alornyo K, Dapaa-Addo C, Botchway E, Kwashie E, Harley Y Curr Res Pharmacol Drug Discov. 2024; 7:100206.
PMID: 39524210 PMC: 11550178. DOI: 10.1016/j.crphar.2024.100206.
Collier J, Kang H, Roh Y, Srivastava C, Grimm S, Jarmusch A Mol Metab. 2024; 90:102052.
PMID: 39505148 PMC: 11613186. DOI: 10.1016/j.molmet.2024.102052.